Popular Bowel Cancer News and Current Events | Page 25

Popular Bowel Cancer News and Current Events, Bowel Cancer News Articles.
Sort By: Most Relevant | Most Recent
Page 25 of 25 | 1000 Results
UCLA study finds brain response differences in the way women with IBS anticipate and react to pain
UCLA researchers found that women with irritable bowel syndrome cannot effectively turn-off a pain modulation mechanism in the brain, which causes them to be more sensitive to abdominal pain, compared to women without IBS. The findings may lead to a greater understanding of the condition and new treatment approaches. (2008-01-08)

Cervical cancer could be eliminated within a century
Cervical cancer could be eliminated worldwide as a public health issue within the next century. This is the conclusion of two studies published today in The Lancet by an international consortium of researchers codirected by Professor Marc Brisson from Université Laval's Faculty of Medicine and the CHU de Québec-Université Laval Research Centre. The researchers are even more optimistic about North America, stating that the disease could be almost completely eliminated by 2040. (2020-01-30)

Link found between muscle damage during childbirth, condition causing fallen bladder, uterus
New research from the University of Michigan Health System establishes one of the strongest connections yet discovered between muscle damage that can occur during vaginal deliveries and pelvic organ prolapse, a condition that causes the uterus, bladder or bowel to fall down later in a woman's life. (2007-01-31)

Losing weight lowered levels of proteins associated with tumor growth
Overweight or obese women who lost weight through diet or a combination of diet and exercise also significantly lowered levels of proteins in the blood that help certain tumors grow, according to a Fred Hutchinson Cancer Research Center study published July 14 in Cancer Research, a journal of the American Association for Cancer Research. (2016-07-14)

Phase II trial of efatutazone shows challenge of matching treatment to population
Work at the University of Colorado Cancer Center led to phase II trial of efatutazone with erlotinib in patients with refractory non-small cell lung cancer. Results are reported today at the American Association for Cancer Research Annual Meeting 2014. While efatutazone did not improve the efficacy of erlotinib in this trial, researchers hope lessons from the trial will allow them to make better future use of the drug or other drugs in its class. (2014-04-08)

Aspirin use may increase pancreatic cancer risk
The many health benefits of regular aspirin use have been well-documented, and include the prevention of certain cancers, heart attacks and strokes, as well as dementia, Alzheimer's disease and cataracts. But a new study advises women that aspirin may not always be helpful. According to research presented today at the American Association for Cancer Research Second Annual International Conference on Frontiers in Cancer Prevention Research, extended regular use of aspirin may be associated with a significantly increased risk of pancreatic cancer among women. (2000-12-31)

Biomarkers predict time to ovarian cancer recurrence
In this issue of the Journal of Clinical Investigation, Roel Verchaak and colleagues at the MD Anderson Cancer Center identify protein biomarkers that are predictive for time of ovarian cancer recurrence and develop a PRotein-driven index of OVARian cancer. (2013-08-15)

Fecal transplants show promise, but need careful monitoring, say experts
The use of fecal transplants to treat severe infections has rapidly become the treatment of choice, but as use increases and widens proper screening of donors, and good long term trials and monitoring are urgently needed in order to provide sensible advice to patients, say experts in The BMJ today. (2015-10-20)

Randomized Contolled Study Shows Neostigmine Is An Effective Treatment For Acute Colonic Pseudo-Obstruction
Researchers at the University of Washington School of Medicine have performed the first randomized controlled clinical trial showing that a painful and even life- threatening bowel condition called acute colonic pseudo- obstruction can be effectively treated with intravenous neostigmine. (1999-05-25)

Researchers identify gene responsible for rare childhood disease
The chromosomal abnormality that causes a rare, but often fatal, disorder that affects infants has been identified by researchers at the University of California, San Diego School of Medicine, who happened to treat two young children with the disease in San Diego -- two of perhaps a dozen children in the entire country diagnosed with the disorder. (2008-07-24)

Popular immunotherapy target turns out to have a surprising buddy
The majority of current cancer immunotherapies focus on PD-L1. This well-studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. Researchers from the Netherlands Cancer Institute publish these findings in the leading journal Nature on Aug. 16. (2017-08-16)

Is a common antimicrobial harmful to gut health?
Scientists have discovered that triclosan, an antimicrobial additive found in thousands of consumer products, causes colon inflammation and exacerbates colon cancer in mice. (2018-05-30)

Tailored lifestyle feedback during colorectal cancer screening improved health behaviors
A program that provided individually tailored lifestyle recommendations for patients undergoing screening for colorectal cancer helped encourage healthy behavior, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. (2018-12-03)

Patients diagnosed with cancer after skipping appointment more likely to die within a year
Cancer patients who miss an urgent referral appointment for their symptoms are 12% more likely to die within 12 months of diagnosis, a major new study has found. The authors of the study say that more support is needed for patients at risk of non-attendance. (2019-09-12)

Dementia may reduce likelihood of a 'good death' for patients with cancer
As the population ages, the number of cancer patients with dementia has increased. A recent study published in Geriatrics & Gerontology International found that cancer patients with dementia were less likely to achieve a 'good death' than those without. (2020-02-05)

University of Cincinnati research unveils possible new combo therapy for head and neck cancer
Researchers at the University of Cincinnati have tested a new combination therapy in animal models to see if they could find a way to make an already effective treatment even better. Since they're using a Food and Drug Administration-approved drug to do it, this could help people sooner than later. (2021-01-22)

Targeted drug may prolong survival of patients with cervical cancer
A new clinical study has found that erlotinib, a targeted antitumor agent, has promising potential to improve treatment for cervical cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the results indicate that larger trials are warranted to determine whether the drug should become part of standard therapy for women with the disease. (2014-03-10)

Researchers identify molecular basis of inflammatory bowel disease
Researchers from the Universities of Cologne and Mainz in Germany, the Mouse Biology Unit of the European Molecular Biology Laboratory (EMBL) in Italy and their collaborators, have now deciphered a molecular signal that triggers chronic intestinal inflammation. (2007-03-14)

SSX, a new family of cancer vaccine targets
Scientists from the Cancer Vaccine Collaborative (CVC) have discovered that the cancer-specific protein, SSX-2, induces a spontaneous immunological reaction against cancer cells in melanoma patients, offering a new target for the development of a therapeutic melanoma vaccine. The first early-phase clinical trial, which will assess the safety and dose profiles of an SSX-2 peptide-based vaccine, is scheduled to begin this year at the CVC Clinical Trials Center in Zürich, Switzerland. (2004-04-15)

After breast cancer diagnosis, risk of thyroid cancer goes up
Breast cancer survivors are at increased risk of developing thyroid cancer, especially within five years of their breast cancer diagnosis, according to a new analysis of a large national database. The study results will be presented Thursday at the Endocrine Society's 97th annual meeting in San Diego. (2015-03-07)

Type of psychotherapy matters in treatment of irritable bowel syndrome
A new study has found that the type of psychotherapy used to treat the gastrointestinal disorder irritable bowel syndrome makes a difference in improving patients' daily functioning. (2016-12-12)

IBS Is Ten Times More Likely After Gastroenteritis
In the year after a bout of bacterial gastroenteritis, patients are ten times more likely to have irritable bowel syndrome (IBS) than the general population, says a study in this week's BMJ. (1999-02-26)

New biomarkers for predicting the spread of colon cancer
Scientists in China are reporting discovery of two proteins present in the blood of people with colon cancer that may serve as the potential biomarkers for accurately predicting whether the disease will spread. Their study is in ACS' Journal of Proteome Research, a monthly publication. (2010-03-03)

High fat diet reduces gut bacteria, Crohn's disease symptoms
Researchers at Case Western Reserve University School of Medicine have shown a high fat diet may lead to specific changes in gut bacteria that could fight harmful inflammation -- a major discovery for patients suffering from Crohn's disease. Crohn's disease, a type of inflammatory bowel syndrome, causes debilitating intestinal swelling, cramping, and diarrhea. The disease affects half a million people in the United States, but its cause is yet unclear. (2017-06-22)

Study links widely-used drug azathioprine to skin cancers
A drug used to treat inflammatory bowel disease, arthritis and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an important contributor to skin cancer development. The research, published in Nature Communications, identified a `strong case for an association' between the drug azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma (cSCC), a common form of skin cancer. (2018-09-10)

Walnuts show protection against ulcerative colitis in early study
Through their complex array of natural compounds and phytochemicals, walnuts provide a multitude of health benefits. A new study says protection against ulcerative colitis may be on that list. (2019-08-12)

Does inflammatory bowel disease carry certain risks during pregnancy?
Pregnant women with inflammatory bowel disease (IBD) are more likely to undergo delivery by Caesarean section and face certain risks during pregnancy, according to an analysis published in Alimentary Pharmacology & Therapeutics. (2020-01-08)

After cancer: The role of primary care in cancer survivorship care
Primary care physicians are treating an increasing number of cancer survivors, yet they have no clear guidance on how best to care for such patients. This study considers how primary care physicians perceive their role in delivering care to cancer survivors. (2020-05-12)

Olive oil could guard against developing ulcerative colitis
Eating more olive oil could help prevent ulcerative colitis, according to a new study coordinated by medical researchers at the University of East Anglia. (2010-05-01)

Short-term hormone therapy plus radiation therapy increases survival for men with early-stage prostate cancer
Short-term hormone therapy (androgen deprivation therapy: ADT) given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group study published in the July 14 issue of the New England Journal of Medicine. (2011-07-13)

Breath test could possibly diagnose colorectal cancer
A new study published in BJS has demonstrated for the first time that a simple breath analysis could be used for colorectal cancer screening. The study is part of the (2012-12-05)

Herceptin found to improve long-term survival of HER2-positive breast cancer patients
VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute-supported clinical trials that demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients. (2014-12-15)

Nut consumption associated with reduced risk of some types of cancer
Nut consumption has long been hypothesized to have a role in preventing both of these diseases, but until now evidence has been inconsistent. A new systematic review and meta-analysis published in Nutrition Reviews on June 16 shows that nut consumption is, indeed, associated with a decreased risk of certain types of cancer, but not type 2 diabetes. (2015-06-16)

Physical activity linked to reduced mortality in breast and colon cancer patients
Physical activity is associated with reduced breast and colon cancer mortality, but there is insufficient evidence on the association for other cancer types, according to a study published May 8 in the Journal of the National Cancer Institute. (2012-05-08)

John Theurer Cancer Center first in New Jersey to offer complete capabilities of Provenge
The John Theurer Cancer Center at Hackensack University Medical is the only cancer center in New Jersey where advanced prostate cancer patients can receive a cell collection process and infusion of Provenge (Sipuleucel-T). Now, patients can find the complete capabilities of this breakthrough immunotherapy in one center led by one physician. (2011-04-04)

Patients with COPD have higher risk of shingles
Patients with chronic obstructive pulmonary disease (COPD) are at greater risk of shingles compared with the general population, according to a study published in Canadian Medical Association Journal. The risk is greatest for patients taking oral steroids to treat COPD. (2011-02-22)

Combining images and genetic data proves gene loss behind aggressive ovarian cancers
Cancer Research UK scientists have shown that loss of a gene called PTEN triggers some cases of an aggressive form of ovarian cancer, called high-grade serous ovarian cancer. (2014-12-16)

Individual intervention with low-income and minority patients increases colonoscopy rates
Patient interventions are necessary to achieve higher rates of colorectal cancer screening in low-income and minority patients, according to two studies in the current issue of Clinical Gastroenterology and Hepatology. (2008-04-01)

Can pathological techniques help identify primary colorectal signet ring cell carcinoma?
A team led by Hsien Lin Sim from Alexandra Hospital has reported an unusual localization of a not so unusual disease (signet ring cell carcinoma). They discussed this very interesting pathological entity and reviewed whether pathological techniques can help identify the primary. (2008-05-20)

Effectiveness of gemcitabine & daily RT for bladder preservation in muscle-invasive bladder cancer
Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for selected patients with muscle-invasive bladder cancer. The phase II NRG Oncology NRG-RTOG 0712 trial evaluated two regimens. One was the prior RTOG standard using 5-flourouracil and cisplatin with twice daily radiation (FCT), and the other a regimen of gemcitabine and daily radiation (GD) which had demonstrated efficacy in single institution clinical trials. (2020-10-26)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.